Just checking in after a 15 hour work day seems like everyone is just holding and waiting...As far as all the CEO chatter I'm happy with recent performance, as long we keep hitting milestones I don't care if time lines extend in a reasonable fashion that's everything in life. If we were still waiting for full set Lympro data ok but he can't control how the market reacts to it. I'm good with GC barring un necessary dilution or a majorly premature up list
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links